President Trump signed an executive order directing changes to the childhood vaccine schedule, calling for spacing out shots and falsely linking vaccines to autism. The order directs the administration to review and potentially alter CDC vaccination recommendations.
Trump Orders Childhood Vaccine Schedule Spacing
Executive order calls for spreading out shots, creating demand uncertainty.

| Ticker | Company | 1-year change |
|---|---|---|
| PFE | Pfizer | −3.6% |
| UNH | UnitedHealth | +20.3% |
Vaccine makers Merck, Pfizer, and Moderna face demand uncertainty from schedule changes.
Vaccine manufacturers face demand uncertainty. Merck MRK, Pfizer PFE, Moderna MRNA, and GSK (GSK) produce childhood vaccines (MMR, DTaP, polio, etc.). If the schedule is spread out, the total number of doses administered per year may decline, reducing near-term revenue. However, the effect depends on implementation; if shots are merely delayed rather than eliminated, lifetime doses remain unchanged. Pediatricians and public health organizations have pushed back, citing safety concerns, which may limit the order's impact.
CVS CVS, Walgreens (WBA), and Rite Aid (RAD) operate vaccination clinics and face potential volume declines if fewer children receive shots on the current schedule. Insurance companies like UnitedHealth UNH and Anthem (ANTM) may see lower preventive care utilization.
Watch for CDC guidance updates, state-level resistance, and pediatrician compliance rates. If the order is blocked or narrowly implemented, the threat to vaccine makers diminishes.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.